Role of α-blockers in the Treatment of Stent-related Symptoms: A Prospective Randomized Control Study
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Efficacy of Tamsulosin 0.4 mg/day in Relieving Double-J Stent-Related Symptoms: A Randomized Controlled StudyJournal of International Medical Research, 2010
- Stent Position Is More Important than α-Blockers or Anticholinergics for Stent-Related Lower Urinary Tract Symptoms after Ureteroscopic Ureterolithotomy: A Prospective Randomized StudyKorean Journal of Urology, 2010
- The Effects of Tolterodine Extended Release and Alfuzosin for the Treatment of Double-J Stent–Related SymptomsJournal of Endourology, 2009
- Effects of Tamsulosin on Lower Urinary Tract Symptoms due to Double-J Stent: A Prospective StudyUrologia Internationalis, 2009
- Effects of specific α-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized studyUrological Research, 2009
- Effect of Tamsulosin in Preventing Ureteral Stent-Related Morbidity: A Prospective StudyJournal of Endourology, 2008
- Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysisBMJ, 2007
- A comparative in vitro study to determine the beneficial effect of calcium‐channel and α 1 ‐adrenoceptor antagonism on human ureteric activityBJU International, 2006
- Is there a role for alpha1-blockers in treating double-J stent-related symptoms?Urology, 2006
- Ureteric stents, far from idealThe Lancet, 2000